Research Article

GLP-1 Gene-Modified Human Umbilical Cord Mesenchymal Stem Cell Line Improves Blood Glucose Level in Type 2 Diabetic Mice

Figure 3

Evaluation of therapeutic effect after cell line injection. Fasting blood glucose levels were measured at 12 hours of fasting, and glucose (2 g/kg) was orally administered to mice. (a) Fasting 12-hour blood glucose of intramuscular injection of Ad-GLP-1 and Ad-GFP at 3 weeks of administration and three weeks of drug withdrawal. (b) Glucose tolerance changes at 3 weeks of administration of Ad-GFP-hUC-MSCs and Ad-GLP-1-hUC-MSCs. (c) Administration of Ad-GFP-hUC-MSCs and Ad-GLP- 1-hUC-MSCs of glucosetolerance at 3 weeks. Data are (). ap, b, compared with the diabetes control mice; c, d, compared with Ad-GFP-hUC-MSC control mice.
(a)
(b)
(c)